πŸ‡ΊπŸ‡Έ FDA
Patent

US 8410081

Treatment of cystic fibrosis

granted A61KA61K31/70A61P

Quick answer

US patent 8410081 (Treatment of cystic fibrosis) held by ACADEMISCH MEDISCH CENTRUM expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/70, A61P, A61P1/00, A61P11/00